{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:47:35Z","timestamp":1774950455526,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"School of Health Sciences"},{"name":"University of KwaZulu-Natal, Westville"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejmech.2015.03.049","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T09:34:42Z","timestamp":1427535282000},"page":"324-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["New paradigm of an old target: An update on structural biology and current progress in drug design towards plasmepsin II"],"prefix":"10.1016","volume":"95","author":[{"given":"Nirnoy","family":"Dan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumendranath","family":"Bhakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.03.049_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2001.64.1","article-title":"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden","volume":"64","author":"Breman","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2015.03.049_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","article-title":"The economic and social burden of malaria","volume":"415","author":"Sachs","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2015.03.049_bib3","article-title":"Malaria parasites go ape","volume":"341","author":"White","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.03.049_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.pt.2004.09.006","article-title":"Clinical features and pathogenesis of severe malaria","volume":"20","author":"Mackintosh","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/14622416.6.1.17","article-title":"Using expression information to discover new drug and vaccine targets in the malaria parasite Plasmodium falciparum","volume":"6","author":"Young","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejmech.2015.03.049_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery - approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BJ20140240","article-title":"From crystal to compound: structure-based antimalarial drug discovery","volume":"461","author":"Drinkwater","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2015.03.049_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059968","article-title":"New targets for drug discovery against malaria","volume":"8","author":"Santos","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.ejmech.2015.03.049_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijantimicag.2012.12.007","article-title":"Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread","volume":"41","author":"Klein","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2015.03.049_bib10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2015.03.049_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/ml4004414","article-title":"Antimalarial drug discovery: from Quinine to the Dream of Eradication","volume":"4","author":"Renslo","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: a drug discovery catalyst for neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.ejmech.2015.03.049_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/fmb.11.45","article-title":"Target identification and validation of novel antimalarials","volume":"6","author":"McNamara","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/156802612799362959","article-title":"Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts","volume":"12","author":"Meyers","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2174\/0929867033457674","article-title":"Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents","volume":"10","author":"Boss","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/med.20082","article-title":"Plasmepsins as potential targets for new antimalarial therapy","volume":"26","author":"Ersmark","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2015.03.049_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2015.03.049_bib18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1110\/ps.8.10.2001","article-title":"Active site specificity of plasmepsin II","volume":"8","author":"Westling","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2015.03.049_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0166-6851(94)90024-8","article-title":"Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum","volume":"64","author":"Dame","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","article-title":"Potencies of human immunodeficiency virus protease inhibitors in\u00a0vitro against plasmodium falciparum and in\u00a0vivo against Murine malaria","volume":"50","author":"Andrews","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.03.049_bib21","doi-asserted-by":"crossref","DOI":"10.1086\/428781","article-title":"Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors","volume":"191","author":"Savarino","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2015.03.049_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/432079","article-title":"Antimalarial effects of HIV proteinase inhibitors: common compounds but structurally distinct enzymes","volume":"192","author":"Wyatt","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2015.03.049_bib23","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1073\/pnas.93.19.10034","article-title":"Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum","volume":"93","author":"Silva","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2015.03.049_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-2836(03)00036-6","article-title":"Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum","volume":"327","author":"Asojo","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1107\/S0907444902014695","article-title":"Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370","volume":"58","author":"Asojo","year":"2002","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2015.03.049_bib26","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1073\/pnas.93.19.10034","article-title":"Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum","volume":"93","author":"Silva","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2015.03.049_bib27","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/ja058211x","article-title":"HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state","volume":"128","author":"Hornak","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2015.03.049_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0969-2126(00)00537-2","article-title":"Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance","volume":"8","author":"Scott","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2015.03.049_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1039\/C4MB00631C","article-title":"Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics","volume":"11","author":"Karubiu","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2015.03.049_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1386207053328093","article-title":"Structure-based drug discovery for Plasmodium falciparum","volume":"8","author":"Mehlin","year":"2005","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"10.1016\/j.ejmech.2015.03.049_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/138945009787581104","article-title":"Protein-drug interaction studies for development of drugs against Plasmodium falciparum","volume":"10","author":"de Azevedo","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2015.03.049_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(02)02241-X","article-title":"Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum","volume":"513","author":"Wyatt","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0014-5793(99)00805-4","article-title":"Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum","volume":"454","author":"Tyas","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1432-1033.1997.00552.x","article-title":"Expression and characterisation of plasmepsin I from Plasmodium falciparum","volume":"244","author":"Moon","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib35","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1021\/jm100233b","article-title":"Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents","volume":"53","author":"Gupta","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molbiopara.2004.01.010","article-title":"Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man","volume":"135","author":"Li","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib37","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/bi047886u","article-title":"Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries","volume":"44","author":"Beyer","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2015.03.049_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1550-7408.1992.tb04856.x","article-title":"Plasmodium falciparum: differential sensitivity in\u00a0vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor)","volume":"39","author":"Bailly","year":"1992","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.ejmech.2015.03.049_bib39","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2015.03.049_bib40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jfluchem.2004.09.014","article-title":"Fluorinated peptidomimetics: synthesis, conformational and biological features","volume":"125","author":"Molteni","year":"2004","journal-title":"J.\u00a0Fluor. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib41","unstructured":"Majer, P., Collins, J., Gulnik, S., and Erickson, J. 1998. Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II, Google Patents."},{"key":"10.1016\/j.ejmech.2015.03.049_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0166-6851(96)02651-5","article-title":"Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole","volume":"79","author":"Luker","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2015.03.049_bib43","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm031106i","article-title":"Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs","volume":"47","author":"Johansson","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib44","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1021\/jm040884n","article-title":"Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II","volume":"48","author":"Johansson","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib45","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/S0960-894X(98)00419-3","article-title":"Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library","volume":"8","author":"Carroll","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib46","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/S0960-894X(98)00554-X","article-title":"Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D","volume":"8","author":"Carroll","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/cc000052k","article-title":"A\u00a0statistical-based approach to assessing the fidelity of combinatorial libraries encoded with electrophoric molecular tags. Development and application of tag decode-assisted single bead LC\/MS analysis","volume":"2","author":"Dolle","year":"2000","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib48","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/S0968-0896(03)00312-2","article-title":"New inhibitors of the malaria aspartyl proteases plasmepsin I and II","volume":"11","author":"Dahlgren","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib49","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/jm980641t","article-title":"Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II","volume":"42","author":"Haque","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/jm020951i","article-title":"Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes","volume":"46","author":"Noteberg","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/cc0301014","article-title":"High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II","volume":"5","author":"Noteberg","year":"2003","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib52","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1016\/j.bmc.2005.06.048","article-title":"Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II","volume":"13","author":"Muthas","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib53","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1021\/bi034131z","article-title":"High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor","volume":"42","author":"Nezami","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2015.03.049_bib54","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/bi0117549","article-title":"Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target","volume":"41","author":"Nezami","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2015.03.049_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/psc.609","article-title":"Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin II","volume":"10","author":"Kiso","year":"2004","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.ejmech.2015.03.049_bib56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0968-0896(02)00643-0","article-title":"New potent C2-symmetric malaria plasmepsin I and II inhibitors","volume":"11","author":"Oscarsson","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib57","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1016\/S0968-0896(03)00339-0","article-title":"C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions","volume":"11","author":"Ersmark","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/jm030933g","article-title":"Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity","volume":"47","author":"Ersmark","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib59","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1021\/jm050463l","article-title":"Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations","volume":"48","author":"Ersmark","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib60","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hlca.200390176","article-title":"Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a Central 7-Azabicyclo[2.2.1]heptane scaffold","volume":"86","author":"Carcache","year":"2003","journal-title":"Helvetica Chim. Acta"},{"key":"10.1016\/j.ejmech.2015.03.049_bib61","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/hlca.200390177","article-title":"A\u00a0new class of inhibitors for the malarial aspartic protease plasmepsin II based on a Central 11-Azatricyclo[6.2.1.02,7]undeca-2,4,6-triene scaffold","volume":"86","author":"Carcache","year":"2003","journal-title":"Helvetica Chim. Acta"},{"key":"10.1016\/j.ejmech.2015.03.049_bib62","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.bmcl.2006.09.027","article-title":"Inhibitors of Plasmepsin II\u2014potential antimalarial agents","volume":"16","author":"Corminboeuf","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib63","doi-asserted-by":"crossref","first-page":"23837","DOI":"10.1074\/jbc.M501519200","article-title":"X-ray structure of plasmepsin II complexed with a potent achiral inhibitor","volume":"280","author":"Prade","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib64","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.45.9.2577-2584.2001","article-title":"New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in\u00a0vitro by inhibiting plasmepsins","volume":"45","author":"Jiang","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.03.049_bib65","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/S0968-0896(02)00207-9","article-title":"Novel and potent anti-malarial agents","volume":"10","author":"Brinner","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib66","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.bmcl.2004.03.030","article-title":"Plasmepsin II inhibition and antiplasmodial activity of Primaquine\u2013Statine \u2018double-drugs'","volume":"14","author":"Romeo","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib67","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1016\/j.jorganchem.2006.09.031","article-title":"Synthesis of 2,3,4,7-tetrahydro-1H-azepines as privileged ligand scaffolds for the design of aspartic protease inhibitors via a ring-closing metathesis approach","volume":"691","author":"Brass","year":"2006","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fitote.2014.01.017","article-title":"Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II","volume":"94","author":"Jin","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2015.03.049_bib69","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.bmcl.2004.03.030","article-title":"Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'","volume":"14","author":"Romeo","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib70","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1016\/j.bmcl.2010.06.099","article-title":"Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution","volume":"20","author":"Miura","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib71","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.bmcl.2011.04.015","article-title":"Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design","volume":"21","author":"McKay","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bmcl.2011.10.018","article-title":"New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships","volume":"22","author":"Saify","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib73","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bmcl.2012.12.029","article-title":"Synthesis of 2-aminomethyl-4-phenyl-1-azabicyclo[2.2.1]heptanes via LiAlH4-induced reductive cyclization of 2-(4-chloro-2-cyano-2-phenylbutyl)aziridines and evaluation of their antimalarial activity","volume":"23","author":"D\u2019hooghe","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib74","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.bmcl.2013.01.128","article-title":"Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening","volume":"23","author":"Song","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib75","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bmcl.2014.02.051","article-title":"Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum","volume":"24","author":"Miura","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.03.049_bib76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bioorg.2014.10.006","article-title":"Antimalarial activity of HIV-1 protease inhibitor in chromone series","volume":"57","author":"Lerdsirisuk","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib77","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.ejmech.2009.03.041","article-title":"Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2","volume":"44","author":"Cunico","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib78","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.bmc.2005.11.003","article-title":"Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV","volume":"14","author":"Ersmark","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib79","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1016\/j.bmc.2008.10.011","article-title":"Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin","volume":"16","author":"Hidaka","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib80","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1016\/j.bmc.2009.06.065","article-title":"alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases","volume":"17","author":"Orrling","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.03.049_bib81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/chem.201202941","article-title":"Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes","volume":"19","author":"Aureggi","year":"2013","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2015.03.049_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cmdc.200500027","article-title":"The potential of P1 site alterations in peptidomimetic protease inhibitors as suggested by virtual screening and explored by the use of C-C-coupling reagents","volume":"1","author":"Weik","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2015.03.049_bib83","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/1439-7633(20021104)3:11<1137::AID-CBIC1137>3.0.CO;2-A","article-title":"De Novo design, synthesis, and in\u00a0vitro evaluation of a new class of nonpeptidic inhibitors of the malarial enzyme plasmepsin II","volume":"3","author":"Carcache","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2015.03.049_bib84","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/cmdc.200900078","article-title":"Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring","volume":"4","author":"Friedman","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2015.03.049_bib85","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1039\/b908489d","article-title":"New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates","volume":"7","author":"Fah","year":"2009","journal-title":"Org. Biomol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415002160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415002160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:33:41Z","timestamp":1566470021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415002160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":85,"alternative-id":["S0223523415002160"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.03.049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New paradigm of an old target: An update on structural biology and current progress in drug design towards plasmepsin II","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}